Reduced Genomic 5-Methylcytosine Content in Human Colonic Neoplasia

Cancer Research

Volumn 48, Issue 5, 1988, Pages 1159-1161

  Feinberg, Andrew P ^a   Gehrke, Charles W ^b   Kuo, Kenneth C ^b   Ehrlich, Melanie ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLCYTOSINE;

COLON ADENOMA; COLON CARCINOMA; GENOME; HUMAN; HUMAN CELL;

ADULT; AGED; COLONIC NEOPLASMS; CYTOSINE; DNA, NEOPLASM; GARDNER SYNDROME; HUMAN; METHYLATION; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T;

EID: 0023848637     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bird, A. P. Use of restriction enzymes to study eukayotic DNA methylation. II. The symmetry of methylated sites supports semi-conservative copying of the methylation pattern. J. Mol. Biol., 118: 49-60, 1978.
2. Pollack, Y., Stein, R., Razin, A., and Cedar, H. Methylation of foreign DNA sequencesin eukaryotic cells. Proc. Natl. Acad. Sci. USA, 77: 6463-6467, 1980.
3. Wigler, M., Levy, D., and Perucho, M. The somatic replication of DNA methylation. Cell, 24: 33-40, 1981.
4. Ehrlich, M., Gama-Sosa, M. A., Huang, L. H. Midgett, R. M., Kuo, K. C., McCune, R. A., and Gehrke, C. Amount and distribution of 5-methylcytosine in human DNA from different types of cells. Nucleic Acids Res., 10: 2709-2721, 1982.
5. Doerfier, W. DNA methylation and gene activity. Annu. Rev. Biochem., 52: 93-124,1983.
6. Razin, A., and Szyf, M. DNA methylation patterns. Formation and function. Biochim. Biophys. Acts, 782: 331-342, 1984.
7. Groudine, M., Eisenman, R., and Weintraub, H. Chromatin structure of endogenous retroviral genes and activation by an inhibitor of DNA methyl ation. Nature (Lond.), 292: 311-317, 1981.
8. Jones, P. A., and Taylor, S. M. Cellular differentiation, cytidine analogs and DNA methylation. Cell, 20: 85-93, 1980.
9. Creusot, F., Acs, G., and Christman, J. K. Inhibition of DNA methyltrans ferase and induction of Friend erythroleukemia cell differentiation by 5- azacytidine and 5-aza-2'-deoxycytidine. J. Biol Chem., 257: 2041-2048, 1982.
10. Benedict, W. F., Banerjee, A., Gardner, A., and Jones, P. A. Induction of morphological transformation in mouse C3H/10T1/2 clone 8 cells and chromosomal damagein hamster A(T1)C1-3 cells by cancer chemotherapeutic agents. Cancer Res., 37: 2202-2208, 1977.
11. Landolph, J. R., and Jones, P. A. Mutagenicity Of 5-azacytidine and related nucleosidesin C3H/10T1/2 C18 and V79 cells. Cancer Res., 42: 817-823, 1982.
12. Carr, B. I., Reilly, J. G., Smith, S. S., Winberg, C., and Riggs, A. The tumongenicity of 5-azacytidine in the male Fischer rate. Carcinogenesis (Lond.), 5: 1583-1590, 1984.
13. Mohandas, T., Sparkes, R. S., and Shapiro, L. J. Reactivation of an inactive x chromosome evidence for X inactivation by DNA methylation. Science (Wash. DC), 211: 393-396, 1981.
14. Schmid, M., Haaf, T., and Grunert, D. 5-azacytidine-induced undercondensations in human chromosomes. Hum. Genet., 67: 257-263, 1984.
15. Hoffman, R. M. Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis. A review and synthesis. Biochim. Biophys. Acts, 738: 49-87, 1984.
16. Gama-Sosa, M. A., Slagel, V. A., Trewyn, R. W., and Ehrlich, M. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res., 11: 6883-6894, 1983.
17. Feinberg, A. P., and Vogelstein, B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature (lond.), 301: 89-91, 1983.
18. Goelz, S. E., Vogelstein, B., Hamilton, S. R., and Feinberg, A. P. Hypome thylation of DNA from benign and malignant human colon neoplasms. Science(Wash. DC), 228: 187-190, 1985.
19. Baylin, S. B., Hoppener, J. W. M., de Bustros, A., Steenburgh, P. H., Lips, C.J.M., and Nelkin, B. D. DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas. Cancer Res., 46: 2917-2922, 1986.
20. Flatau, E., Bogenmann, E., and Jones, P. A. Variable 5-methylcytosine levels in human tumor cells lines and fresh podiatric tumor explants. Cancer Res., 43:4901-4905, 1983.
21. Vogelstem, B., Fearon, E. R., Hamilton, S. R., and Feinberg, A. P. Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science(Wash. DC), 227: 642-645, 1985.
22. Davenport, R. D., and McKeever, P. E. DNA content and marker expression in human glioma explants. Acts Neuropathol., 331: 1-4, 1987.
23. Gehrke, C. W., McCune, R. A., Gama-Sosa, M. A., Ehrlich, M., and Kuo, K. C. Quantitative reversed-phase high performance liquid chromatography of major and modified nucleosides in DNA. J. Chromatogr., 301: 199-219, 1984.
24. Kuo, K. C., McCune, R. A., Gehrke, C. W., and Ehrlich, M. Quantitative reversed-phase high performance liquid chromatographic determination of major and modified deoxyribonucleosides in DNA. Nucleic Acids Res., 8: 4763-4776, 1980.
25. Snedecor, G. W., and Cochran, W. C. Statistical methods, Ed. 7, pp. 1183-1206. Ames, IA: Iowa State University Press, 1980.
26. Wilson, M. J., Shivapurkar, N., and Poirier, L. A. Hypomethylation of hepatic nuclear DNA in rats fed with a carcinogenic methyl-deficient diet. Biochem. J., 218: 987-990, 1984.
27. Lynch, H. T., Kimberling, W. J., Biscone, K. A., Lynch, J. F., Wagner, C. A., Brennan, K., Mailliard, J. A., Johnson, P. S., Soon, J. S., and McKenna, P. J. Familial heterogeneity of colon cancer. Cancer(Phila.), 57: 2089-2096, 1986.
28. Berini, R. Y., and Kahn, E. Clinical Genetics Handbook, pp. 244-248. New York: National Genetics Foundation, Inc., 1987.
29. Feinberg, A. P., and Vogelstein, B. Hypomethylation of rat oncogenesin primary human cancers. Biochem. Biophys. Res. Commun., 111: 47-54, 1983.